News

Cookie Notification

We use cookies to collect information about how our website is used and to improve the visitor experience. You can change your browser's cookie settings at any time. Please review our privacy policy for more information. OK

Media Contact

Stephen Schultz
VP Investor Relations (U.S.)
T: 917-280-2424 / 401 500 6570
sschultz@gwpharm.com
 

Recent Press Releases

Dec 24, 2015
London, UK; 24 December 2015: GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing
Dec 07, 2015
- Three Phase 3 Epidiolex clinical trials fully recruited above target sample size – on track for initial data in Q1 2016 -
Nov 30, 2015
- Change to after market on 7 December to facilitate inclusion of additional Epidiolex data -
Nov 25, 2015
London, UK, 25 Nov 2015: GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, “GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics
Nov 24, 2015
London, UK, 24 Nov 2015: GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, “GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprie
Nov 24, 2015
London, UK, 24 Nov 2015: GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, “GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprie
Oct 27, 2015
- Consistent with previously announced results from the initial Phase 3 trial, remaining trials fail to show superiority over placebo -
Oct 27, 2015
London, UK, 27 Oct 2015: GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics fro
Sep 15, 2015
London, UK, 15 Sept 2015: GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics fr

Pages